Phibro Animal Health Corporation (PAHC) — Financial statements
Income statement, balance sheet, and cash flow for Phibro Animal Health Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,296↑27.4% | 1,018↑4.1% | 978↑3.8% | 942↑13.1% | 833 | |
| Cost of Revenue | 896↑27.2% | 705↑3.7% | 680↑3.5% | 657↑16.9% | 562 | |
| Gross Profit | 400↑27.7% | 313↑5.0% | 298↑4.5% | 285↑5.2% | 271 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 289↑11.4% | 260↑14.7% | 226↑9.7% | 206↑5.0% | 197 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 289↑11.4% | 260↑14.7% | 226↑9.7% | 206↑5.0% | 197 | |
| Total Costs & Expenses | 1,186↑23.0% | 964↑6.4% | 906↑5.0% | 863↑13.8% | 758 | |
| Operating Results | ||||||
| Operating Income | 110↑107.2% | 53↓25.8% | 72↓9.0% | 79↑5.5% | 75 | |
| Depreciation & Amortization | 46↑26.1% | 36↑6.4% | 34↑4.0% | 33↑2.6% | 32 | |
| EBITDA | 147↑112.6% | 69↓34.9% | 106↓9.5% | 117↑6.3% | 110 | |
| EBIT | 101↑207.9% | 33↓54.3% | 72↓14.7% | 84↑7.8% | 78 | |
| Interest & Other Income | ||||||
| Net Interest Income | -31↓75.1% | -17↓19.9% | -15↓29.3% | -11↓18.0% | -10 | |
| Interest Income | 3↓41.4% | 4↑33.4% | 3↑311.2% | 0.82↓2.6% | 0.84 | |
| Interest Expense | 33↑51.3% | 22↑22.4% | 18↑48.3% | 12↑16.3% | 10 | |
| Non-Operating Income | 9↓54.9% | 20↑11908.7% | -0.17↑96.8% | -5↓57.1% | -3 | |
| Other Income / Expenses | -42↓0.2% | -42↓138.5% | -18↓166.9% | -7↑20.7% | -8 | |
| Income Before Tax | 68↑522.9% | 11↓79.8% | 54↓25.2% | 72↑8.8% | 66 | |
| Income Tax Expense | 20↑132.1% | 9↓60.4% | 21↓7.3% | 23↑91.6% | 12 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 48↑1897.7% | 2↓92.6% | 33↓33.7% | 49↓9.6% | 54 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 48↑1897.7% | 2↓92.6% | 33↓33.7% | 49↓9.6% | 54 | |
| Bottom-Line Net Income | 48↑1897.7% | 2↓92.6% | 33↓33.7% | 49↓9.6% | 54 | |
| EPS (Basic) | 1.19↑1883.3% | 0.06↓92.6% | 0.81↓33.1% | 1.21↓9.7% | 1.34 | |
| EPS (Diluted) | 1.19↑1883.3% | 0.06↓92.6% | 0.81↓33.1% | 1.21↓9.7% | 1.34 | |
| Weighted Average Shares | 41↓0.0% | 41↑0.0% | 41↑0.0% | 41↑0.0% | 41 | |
| Weighted Average Diluted Shares | 41↑0.4% | 41↑0.0% | 41↑0.0% | 41↑0.0% | 41 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.